Wall Street's 76 Biggest Earnings Winners
Through July 24, 86 percent of the S&P 500 companies that reported second-quarter earnings exceeded analyst expectations, well above the 10-year average of 76 percent.
Beone Medicines Ltd. (ONC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 35,180 | $10,025,244 | -16% | 2.7% |
| 2. | Walleye Capital Will England | 723 | $206,033 | -97% | 0% |
| 3. | 300 | $85,491 | 0% | ||
| 4. | Bayforest Capital Theodoros Tsagaris | 71 | $20,233 | -39% | 0.02% |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $302.06 | 165,529 | $49,999,938.03 | 18,943,802 | 2021-09-10 | Filing | |
| $108.00 | 5,231,900 | $565,045,200.00 | 5,250,491 | 2018-08-02 | Filing | |
| $108.00 | 582,200 | $62,877,600.00 | 600,791 | 2018-08-02 | Filing | |
| $101.00 | 1,645,148 | $166,159,948.00 | 5,121,404 | 2018-01-18 | Filing | |
| $101.00 | 335,050 | $33,840,050.00 | 708,025 | 2018-01-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $312.72 | 1,157 | $361,811.26 | 0 | 2026-08-03 | Filing | |
| $323.69 | 1,044 | $337,932.36 | 0 | 2026-07-30 | Filing | |
| $325.00 | 1,669 | $542,425.00 | 0 | 2026-07-22 | Filing | |
| $320.06 | 2,340 | $748,936.42 | 0 | 2026-07-21 | Filing | |
| $319.29 | 15,807 | $5,047,018.61 | 2,340 | 2026-07-21 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 845,729 | $241,007,393 | 0.65% | |
| 2. | 694,618 | $197,945,363 | 0% | |
| 3. | 223,445 | $63,681,825 | 0.32% | |
| 4. | 100,698 | $28,695,909 | 0.02% | |
| 5. | 65,524 | $18,672,374 | 0.16% |
News See All
Is BeOne Medicines AG (ONC) Stock Positioned for Growth After Encouraging ASCO Cancer Data?
TheFly reported on June 2 that RBC Capital analyst Leonid Timashev increased the firm’s price target on ONC to $436 from $425 while maintaining an Outperform rating on the shares.
10 Most Promising Cancer Stocks According to Wall Street Analysts
Regardless of the state of the economy, the pharmaceutical business has continued to be one of the healthcare market's most robust sectors thanks to the consistent need for medications, vaccinations, ...
10 Most Promising Long-Term Stocks to Buy According to Analysts
On June 11, Emily Roland, Manulife John Hancock Investment Management, Co-Chief Investment Strategist, joined 'Squawk Box' on CNBC to describe the current market environment as a momentum freight train...
10 Most Promising Healthcare Stocks According to Wall Street Analysts
The US healthcare sector has trailed the broader market for three consecutive years, returning just 0.3% in 2023, 0.9% in 2024, and 12.5% in 2025.
15 High-Growth Large-Cap Stocks to Invest In Now
Expect US stocks to get an additional boost on a rotation into cyclical, economically sensitive industries that have lagged amid the US-Iran war.
10 Best European Growth Stocks to Buy
European growth stocks are getting another look as investors search for earnings growth outside the usual U.S. mega-cap playbook.
10 Best Aggressive Growth Stocks to Buy According to Wall Street Analysts
On May 13, Reuters reported that Morgan Stanley increased its annual target for the benchmark S&P 500 index.
8 Most Promising Biotech Stocks to Buy Now
On January 14, Reuters reported that investors foresee a comeback in the US biotech sector in 2026, with more IPO activity and stronger deal-making as legislative risks ease.
7 Fastest Growing European Stocks to Invest In
European stocks are getting a closer look again, and not only because investors want to diversify away from a crowded U.S. trade.
Hedge Fund Resource Center